Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Morgenstern

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2013
Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancerAmey Bandekar, Charles Zhu, Rohit Jindal, et al.
Current Radiopharmaceuticals|May 8, 2018
An Overview of Targeted Alpha Therapy with <sup>225</sup>Actinium and <sup>213</sup>BismuthAlfred Morgenstern, Christos Apostolidis, Clemens Kratochwil, et al.
Dalton Transactions (Cambridge, England : 2003)|January 28, 2010
Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for (230)UGilles Montavon, Urska Repinc, Christos Apostolidis, et al.
Oncoimmunology|May 6, 2015
Using α radiation to boost cancer immunity?Jean-Baptiste Gorin, Yannick Guilloux, Alfred Morgenstern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibodyStefanie Bloechl, Roswitha Beck, Christof Seidl, et al.
Future Microbiology|September 12, 2013
Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cellsRuth A Bryan, Zewei Jiang, Alfred Morgenstern, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2009
Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthraxJohanna Rivera, Antonio S Nakouzi, Alfred Morgenstern, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2011
Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent miceZewei Jiang, Ruth A Bryan, Alfred Morgenstern, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2008
Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformansRuth A Bryan, Xianchun Huang, Alfred Morgenstern, et al.
Polish Archives of Internal Medicine|June 14, 2022
Innovative radioisotope therapy for patients with neuroendocrine tumors using an α (225Ac) emitter labeled somatostatin analog: octreotate. A promising new treatment for advanced progressive neuroendocrine neoplasmsTadeusz Budlewski, Zbigniew J Król, Frank Bruchertseifer, et al.
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2013
Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancerAmey Bandekar, Charles Zhu, Rohit Jindal, et al.
Current Radiopharmaceuticals|May 8, 2018
An Overview of Targeted Alpha Therapy with <sup>225</sup>Actinium and <sup>213</sup>BismuthAlfred Morgenstern, Christos Apostolidis, Clemens Kratochwil, et al.
Dalton Transactions (Cambridge, England : 2003)|January 28, 2010
Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for (230)UGilles Montavon, Urska Repinc, Christos Apostolidis, et al.
Oncoimmunology|May 6, 2015
Using α radiation to boost cancer immunity?Jean-Baptiste Gorin, Yannick Guilloux, Alfred Morgenstern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibodyStefanie Bloechl, Roswitha Beck, Christof Seidl, et al.
Future Microbiology|September 12, 2013
Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cellsRuth A Bryan, Zewei Jiang, Alfred Morgenstern, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2009
Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthraxJohanna Rivera, Antonio S Nakouzi, Alfred Morgenstern, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2011
Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent miceZewei Jiang, Ruth A Bryan, Alfred Morgenstern, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2008
Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformansRuth A Bryan, Xianchun Huang, Alfred Morgenstern, et al.
Polish Archives of Internal Medicine|June 14, 2022
Innovative radioisotope therapy for patients with neuroendocrine tumors using an α (225Ac) emitter labeled somatostatin analog: octreotate. A promising new treatment for advanced progressive neuroendocrine neoplasmsTadeusz Budlewski, Zbigniew J Król, Frank Bruchertseifer, et al.
Pageof 18